Corcept Therapeutics (CORT) EPS (Basic) (2010 - 2026)
Corcept Therapeutics (CORT) posted EPS (Basic) of $0.4 for Q2 2026, up 233.85% sequentially from -$0.3 in Q1 2026, and up 20.29% YoY from $0.33 in Q2 2025.
Corcept Therapeutics (CORT) EPS (Basic) (2010 - 2026) Analysis & Trends
Corcept Therapeutics has reported EPS (Basic) for 17 years, with the latest figure at $0.4 in Q2 2026.
- Quarterly EPS (Basic) rose 20.29% year-over-year to $0.4 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $0.51 (down 59.42% YoY) and the FY2025 annual result came in at $0.95, down 30.17% from the prior year.
- EPS (Basic) climbed to $0.4 in Q2 2026 per CORT's latest filing, from -$0.3 in the prior quarter.
- Over five years, EPS (Basic) peaked at $0.45 in Q3 2024 and troughed at -$0.3 in Q1 2026.
- A 5-year average of $0.24 and a median of $0.27 in 2023 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2023 and 2026: EPS (Basic) surged 94.24% in 2023, then slumped 253.31% in 2026.
- Over 5 years, EPS (Basic) stood at $0.15 in 2022, then soared by 94.24% to $0.3 in 2023, then dropped by 2.11% to $0.29 in 2024, then declined by 21.82% to $0.23 in 2025, then soared by 73.76% to $0.4 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered $0.4, -$0.3, and $0.23 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Corcept Therapeutics | 12.37 Bn | 12.07 Bn | 252.09 Mn | 0.40 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.40 |
| Mar 31, 2026 | -0.30 |
| Dec 31, 2025 | 0.23 |
| Sep 30, 2025 | 0.19 |
| Jun 30, 2025 | 0.33 |
| Mar 31, 2025 | 0.19 |
| Dec 31, 2024 | 0.29 |
| Sep 30, 2024 | 0.45 |
| Jun 30, 2024 | 0.34 |
| Mar 31, 2024 | 0.27 |
| Dec 31, 2023 | 0.30 |
| Sep 30, 2023 | 0.31 |
| Jun 30, 2023 | 0.27 |
| Mar 31, 2023 | 0.15 |
| Dec 31, 2022 | 0.15 |
| Sep 30, 2022 | 0.32 |
| Jun 30, 2022 | 0.26 |
| Mar 31, 2022 | 0.22 |
| Dec 31, 2021 | 0.28 |
| Sep 30, 2021 | 0.26 |